View Clinical Trial (Medical Research Study)
Alzheimer's Disease Genetics Study
| City: |
|
Nationwide |
| State: |
|
Indiana |
| Zip Code: |
|
|
| Conditions: |
|
Alzheimer Disease - Late Onset Alzheimer Disease - Dementia |
| Purpose: |
|
The purpose of the Alzheimer's Disease Genetics Study is to identify the genes that are
responsible for causing Alzheimer's Disease (AD). One of the ways in which the risk factor
genes for late onset AD can be investigated is by identifying and collecting genetic
material from families with multiple members diagnosed with AD or dementia.
|
| Study Summary: |
|
The purpose of the Alzheimer's Disease Genetics Study is to help identify the genes that may
be responsible for causing Alzheimer's Disease (AD) by collecting genetic material from
families with multiple members diagnosed with AD. Qualifying families will have two living
blood-related individuals who have been diagnosed with or are showing symptoms of AD or
dementia. Local study sites are located all over the United States, and arrangements may be
made for eligible families who do not live near a participating site. The biological samples
and data from these families will be made available to qualified researchers, who must sign
a Materials Transfer Agreement (MTA) in order to protect the privacy rights of study
participants before receiving DNA and data.
|
| Criteria: |
|
Inclusion Criteria:
- Two living family members diagnosed with AD or other dementia with any age of onset
- Biological samples available
- Fresh blood, or
- Immortalized lymphoblastic cell lines, or
- 3-5 grams of frozen cerebral cortex; fixed samples are not accepted
Please note: this study does not include genetic counseling; because no personal
identifying information such as name or date of birth is attached to samples, results of
individual tests are not available to participants or family members.
Exclusion Criteria:
- Does not meet inclusion criteria
- Member of a family that was included in the National Institute of Mental Health AD
Genetics Sib Pair collection
|
| NCT ID: |
|
NCT00064870 |
| Primary Contact: |
|
Principal Investigator
Tatiana M. Foroud, PhD
National Cell Repository for Alzheimer's Disease (NCRAD), Indiana University
Study Coordinator
Phone: 1-800-526-2839
Email: alzstudy@iupui.edu
|
| Backup Contact: |
|
N/A |
| Location Contact: |
|
Nationwide, Indiana
United States
NCRAD Study Coordinator
Phone: 800-526-2839
Email: alzstudy@iupui.edu
Site Status: Recruiting |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 25, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|